Annual Current Liabilities:
$193.68M+$48.20M(+33.13%)Summary
- As of today, ANIP annual current liabilities is $193.68 million, with the most recent change of +$48.20 million (+33.13%) on December 31, 2024.
- During the last 3 years, ANIP annual current liabilities has risen by +$106.14 million (+121.26%).
- ANIP annual current liabilities is now at all-time high.
Performance
ANIP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$270.56M+$33.72M(+14.24%)Summary
- As of today, ANIP quarterly current liabilities is $270.56 million, with the most recent change of +$33.72 million (+14.24%) on September 30, 2025.
- Over the past year, ANIP quarterly current liabilities has increased by +$80.62 million (+42.45%).
- ANIP quarterly current liabilities is now at all-time high.
Performance
ANIP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ANIP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +33.1% | +42.5% |
| 3Y3 Years | +121.3% | +231.4% |
| 5Y5 Years | +214.0% | +256.5% |
ANIP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +121.3% | at high | +231.4% |
| 5Y | 5-Year | at high | +214.0% | at high | +256.5% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
ANIP Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $270.56M(+14.2%) |
| Jun 2025 | - | $236.84M(+17.4%) |
| Mar 2025 | - | $201.81M(+4.2%) |
| Dec 2024 | $193.68M(+33.1%) | $193.68M(+2.0%) |
| Sep 2024 | - | $189.93M(+35.7%) |
| Jun 2024 | - | $139.98M(+2.3%) |
| Mar 2024 | - | $136.89M(-5.9%) |
| Dec 2023 | $145.48M(+46.3%) | $145.48M(+8.3%) |
| Sep 2023 | - | $134.35M(+9.3%) |
| Jun 2023 | - | $122.86M(-2.4%) |
| Mar 2023 | - | $125.83M(+26.5%) |
| Dec 2022 | $99.44M(+13.6%) | $99.44M(+21.8%) |
| Sep 2022 | - | $81.63M(-15.2%) |
| Jun 2022 | - | $96.31M(+21.1%) |
| Mar 2022 | - | $79.53M(-9.1%) |
| Dec 2021 | $87.54M(+11.4%) | $87.54M(+3.1%) |
| Sep 2021 | - | $84.87M(-5.1%) |
| Jun 2021 | - | $89.45M(+8.1%) |
| Mar 2021 | - | $82.77M(+5.3%) |
| Dec 2020 | $78.56M(+27.4%) | $78.56M(+3.5%) |
| Sep 2020 | - | $75.90M(-4.0%) |
| Jun 2020 | - | $79.09M(-0.3%) |
| Mar 2020 | - | $79.36M(+28.7%) |
| Dec 2019 | $61.68M(-62.7%) | $61.68M(-63.9%) |
| Sep 2019 | - | $170.71M(+2.3%) |
| Jun 2019 | - | $166.79M(+1.0%) |
| Mar 2019 | - | $165.07M(-0.3%) |
| Dec 2018 | $165.55M(+322.0%) | $165.55M(+253.0%) |
| Sep 2018 | - | $46.90M(+18.2%) |
| Jun 2018 | - | $39.68M(+0.1%) |
| Mar 2018 | - | $39.65M(+1.1%) |
| Dec 2017 | $39.23M(+22.8%) | $39.23M(+7.8%) |
| Sep 2017 | - | $36.38M(+28.6%) |
| Jun 2017 | - | $28.29M(-12.7%) |
| Mar 2017 | - | $32.42M(+1.5%) |
| Dec 2016 | $31.95M(+171.8%) | $31.95M(+4.8%) |
| Sep 2016 | - | $30.49M(+23.3%) |
| Jun 2016 | - | $24.73M(+52.6%) |
| Mar 2016 | - | $16.21M(+37.9%) |
| Dec 2015 | $11.76M(-11.2%) | $11.76M(-3.6%) |
| Sep 2015 | - | $12.19M(+75.4%) |
| Jun 2015 | - | $6.95M(-23.4%) |
| Mar 2015 | - | $9.07M(-31.4%) |
| Dec 2014 | $13.23M(+274.0%) | $13.23M(+62.5%) |
| Sep 2014 | - | $8.14M(+112.8%) |
| Jun 2014 | - | $3.83M(-16.1%) |
| Mar 2014 | - | $4.56M(+28.9%) |
| Dec 2013 | $3.54M(-66.6%) | $3.54M(-46.4%) |
| Sep 2013 | - | $6.60M(+7.0%) |
| Jun 2013 | - | $6.16M(-33.9%) |
| Mar 2013 | - | $9.33M(-12.0%) |
| Dec 2012 | $10.59M | $10.59M(-3.0%) |
| Sep 2012 | - | $10.92M(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $16.37M(+169.1%) |
| Mar 2012 | - | $6.08M(-15.8%) |
| Dec 2011 | $7.23M(-11.7%) | $7.23M(-37.1%) |
| Sep 2011 | - | $11.50M(+0.2%) |
| Jun 2011 | - | $11.48M(-9.1%) |
| Mar 2011 | - | $12.63M(+54.4%) |
| Dec 2010 | $8.18M(+108.2%) | $8.18M(+15.3%) |
| Sep 2010 | - | $7.10M(+6.1%) |
| Jun 2010 | - | $6.69M(+7.5%) |
| Mar 2010 | - | $6.22M(+58.4%) |
| Dec 2009 | $3.93M(+2.0%) | $3.93M(-17.7%) |
| Sep 2009 | - | $4.78M(+28.5%) |
| Jun 2009 | - | $3.72M(+19.7%) |
| Mar 2009 | - | $3.10M(-19.4%) |
| Dec 2008 | $3.85M(+154.2%) | $3.85M(-15.7%) |
| Sep 2008 | - | $4.57M(+26.2%) |
| Jun 2008 | - | $3.62M(+23.7%) |
| Mar 2008 | - | $2.93M(+93.1%) |
| Dec 2007 | $1.52M(-64.7%) | $1.52M(-32.2%) |
| Sep 2007 | - | $2.23M(-14.4%) |
| Jun 2007 | - | $2.61M(+7.4%) |
| Mar 2007 | - | $2.43M(-43.5%) |
| Dec 2006 | $4.30M(+61.3%) | $4.30M(+158.5%) |
| Sep 2006 | - | $1.66M(-27.8%) |
| Jun 2006 | - | $2.30M(-15.8%) |
| Mar 2006 | - | $2.73M(+2.6%) |
| Dec 2005 | $2.67M(+39.8%) | $2.67M(+77.2%) |
| Sep 2005 | - | $1.50M(-3.0%) |
| Jun 2005 | - | $1.55M(-14.4%) |
| Mar 2005 | - | $1.81M(-5.0%) |
| Dec 2004 | $1.91M(+116.4%) | $1.91M(+42.7%) |
| Sep 2004 | - | $1.34M(+13.6%) |
| Jun 2004 | - | $1.18M(+2.6%) |
| Mar 2004 | - | $1.15M(+30.1%) |
| Dec 2003 | $881.20K(-29.9%) | $881.00K(+25.9%) |
| Sep 2003 | - | $700.00K(-2.9%) |
| Jun 2003 | - | $721.00K(+29.9%) |
| Mar 2003 | - | $555.00K(-55.8%) |
| Dec 2002 | $1.26M(+35.4%) | $1.26M(+81.2%) |
| Sep 2002 | - | $693.00K(-5.7%) |
| Jun 2002 | - | $735.00K(+8.4%) |
| Mar 2002 | - | $678.00K(-26.9%) |
| Dec 2001 | $927.80K(-1.4%) | $928.00K(-9.8%) |
| Sep 2001 | - | $1.03M(+9.4%) |
| Jun 2001 | - | $941.00K(+18.5%) |
| Mar 2001 | - | $794.00K(-15.6%) |
| Dec 2000 | $941.30K(+186.0%) | $941.00K(+35.0%) |
| Sep 2000 | - | $697.00K(+182.2%) |
| Jun 2000 | - | $247.00K(-13.9%) |
| Mar 2000 | - | $287.00K(-12.8%) |
| Dec 1999 | $329.10K(-59.8%) | - |
| Dec 1999 | - | $329.00K(-8.1%) |
| Sep 1999 | - | $358.00K |
| Dec 1998 | $817.90K | - |
FAQ
- What is ANI Pharmaceuticals, Inc. annual current liabilities?
- What is the all-time high annual current liabilities for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is ANI Pharmaceuticals, Inc. quarterly current liabilities?
- What is the all-time high quarterly current liabilities for ANI Pharmaceuticals, Inc.?
- What is ANI Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is ANI Pharmaceuticals, Inc. annual current liabilities?
The current annual current liabilities of ANIP is $193.68M
What is the all-time high annual current liabilities for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high annual current liabilities is $193.68M
What is ANI Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, ANIP annual current liabilities has changed by +$48.20M (+33.13%)
What is ANI Pharmaceuticals, Inc. quarterly current liabilities?
The current quarterly current liabilities of ANIP is $270.56M
What is the all-time high quarterly current liabilities for ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. all-time high quarterly current liabilities is $270.56M
What is ANI Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, ANIP quarterly current liabilities has changed by +$80.62M (+42.45%)